Holen Sie sich die Stockscreener-App
0.7873
3.24%
-0.0264
Handel nachbörslich:
.73
-0.0573
-7.28%
Beyondspring Inc Aktie (BYSI) Neueste Nachrichten
BeyondSpring Inc. Announces FDA Fast Track Designation For Plinabulin And Docetaxel In Post-ICI Non-Squamous NSCLC - marketscreener.com
BYSI Forecast — Price Target — Prediction for 2027 - TradingView
'Beyond Spring and Fall': Apple Prepares Organization Restructure for Accelerating Product Launches - TradingView
BeyondSpring Receives FDA Fast Track for Plinabulin - grafa.com
Form 8K BeyondSpring Inc For: 29 September By Investing.com - Investing.com Nigeria
BeyondSpring Secures FDA Fast Track Designation for Plinabulin as DUBLIN-4 Phase 3 Trial Advances - Yahoo Finance
Form 424B5 BeyondSpring Inc For: 29 September By Investing.com - Investing.com Nigeria
BeyondSpring launches ATM program to bolster financing - TipRanks
FDA grants fast track status to BeyondSpring’s lung cancer drug - Investing.com
Beyondspring Inc Entered Into Open Market Sale Agreement Under Which Co May Offer And Sell Up To 9.2 Million Ordinary Shares - TradingView
About 221 patients are expected to enroll in China, with an investor helping fund the lung cancer trial. - Stock Titan
BeyondSpring Announces FDA Fast Track Designation for - GlobeNewswire
Beyondspring Inc (BYSI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Premarket movers: GRML and BTTC lead gainers, IMCC and DLXY lead losers - ChartMill
Beyondspring Stock Price Forecast. Should You Buy BYSI? - StockInvest.us
BeyondSpring Faces Nasdaq Noncompliance Over Minimum Bid Price - TipRanks
BeyondSpring Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
BeyondSpring (BYSI): Plinabulin Advances While the Balance Sheet Reaches a Critical Threshold - news.alphastreet.com
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
BeyondSpring (NASDAQ: BYSI) Announces 2026 Annual General Meeting with Virtual Access - kalkinemedia.com
BeyondSpring Inc. SEC Filing (Sep 3, 2026) - stocktitan.net
BeyondSpring (BYSI) plans Oct. 13 vote on 2026 auditor - stocktitan.net
Intelligent Bio Solutions Raises Up to $15M in Private Placement - Minichart
BeyondSpring (BYSI) EPS and Revenue: The Company Lists Its Latest Available Figures for This Review; Stock Move: The Stock Records a Flat Reaction in the Current UpdateAnalyst Coverage Count - vinanet.vn
BeyondSpring (BYSI) Results Versus Estimates: Available Data Shows the Latest Reported Performance in Latest Trading; Market Reaction: Shares Close 0.28% Lower in the Current UpdatePositive Surprise Momentum - vinanet.vn
BeyondSpring (BYSI) Range: Adds 4.89% to Close at $0.75 in the Current Update; Market Levels: the Supplied Trading Band Runs From $0.71 to $0.79 in the Latest SessionSMA Signal - vinanet.vn
BeyondSpring Inc. (BYSI) Reports Q2 Loss of $0.02 - StreetInsider
BeyondSpring (BYSI) Q2 Results Highlight Challenges Amid High Price-to-Sales Valuation - GuruFocus
BeyondSpring (BYSI) Slides 15.78% to $0.84 as Key Support NearsValue Area High - vinanet.vn
BYSI Q1 2026 Earnings: Net Loss Per Share of $0.05 Reported as Shares Slide 15.78%Investor Earnings Call - vinanet.vn
BeyondSpring (BYSI) Plunges 15.78% to $0.84 as Key Support at $0.80 Comes into FocusMax Pain Level - siam.in
BeyondSpring Reports Second-Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
BeyondSpring Cash Drops to $6.4M, Escalating Going-Concern Risk - minichart.com.sg
BeyondSpring Cash Drops to $6.5M as DUBLIN-4 Trial Funding Looms - Minichart
BeyondSpring Q2 loss narrows to $849k; EPS improves to $(0.02) - scanx.trade
BeyondSpring Inc. (BYSI) founders disclose 5.29M shares each in 13G/A - Stock Titan
BYSI: Net loss increased to $5.7M in Q2 2026, with urgent need for new funding amid ongoing R&D - TradingView
BeyondSpring (BYSI) posts deeper H1 2026 loss and flags going concern risk - Stock Titan
BeyondSpring Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BeyondSpring Posts $5.7 Million Second-Quarter Net Loss - Quiver Quantitative
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
BYSI Q1 2026 Earnings: Loss Per Share of $0.05 Reported as Shares Rise 7.01%Earnings Call Transcript - vinanet.vn
Beyondspring Inc (BYSI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Vascular Disrupting Agents Market - Future Market Insights
Beyondspring Inc (BYSI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BeyondSpring Inc. (BYSI) Q1 2026 Earnings: Pre-Revenue Biotech Reports Narrowed Loss Amid Pipeline ProgressShort-Term Outlook - dars.gov.et
BYSI Q1 2026 Earnings: Narrowed Loss Reflects Continued Clinical ProgressTax Rate Impact - dars.gov.et
Beyondspring Inc (BYSI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BYSI|Beyondspring Inc|Price:0.720|Chg%:-0.002 - TradingKey
Beyondspring Inc (BYSI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Beyondspring Inc (BYSI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Beyondspring Inc (BYSI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BYSI Q1 2026 Earnings: EPS Loss of $0.05 Reported; Shares Rise 3.7%Subscription Growth Report - dars.gov.et
Beyondspring Inc (BYSI) Income Statement - TradingKey
BYSI|Beyondspring Inc|Price:0.717|Chg%:+0.005 - TradingKey
Beyondspring Inc (BYSI) Valuation: PE, PB & Fair Value Analysis - TradingKey
BYSI|Beyondspring Inc|Price:0.775|Chg%:+0.033 - TradingKey
BeyondSpring, Inc. Revenue Breakdown – NASDAQ:BYSI - TradingView
BYSI|Beyondspring Inc|Price:1.120|Chg%:+0.040 - TradingKey
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):